Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000097:blood / Q000494:pharmacology*; D002247:Carbon Isotopes; D002473:Cell Wall / Q000032:analysis; D005998:Glycine / Q000378:metabolism; D006358:Hot Temperature; D066298:In Vitro Techniques; D008248:Lysostaphin / Q000494:pharmacology; D051379:Mice; D010068:Oxacillin / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D011506:Proteins / Q000032:analysis; D013210:Staphylococcus / Q000187:drug effects*; D014357:Trypsin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002247:Carbon Isotopes; D011506:Proteins; D014357:Trypsin; D008248:Lysostaphin; D010400:Penicillin G; D005998:Glycine; D010068:Oxacillin